Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
ImmunoGen Inc. (NASDAQ:IMGN) Signs Development And Commercialization Partnership For Mirvetuximab With…
Jaguar Health Inc. (NASDAQ:JGAX) On Track With Capitalization Strategy As It…
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Winds Down Probuphine sales In The US…
Akebia Therapeutics Inc. (NASDAQ:AKBA) Presents Positive INNO¬2VATE Phase 3 Clinical Vadadustat…
Gilead Sciences Inc. (NASDAQ:GILD) Receives FDA Approval For Remdesivir In Treating…
Finance
The Contrarian Opportunity in Sports Stocks (CHDN, DKNG, BTDG, DKS)
Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical…
OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply…
TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence…
British Journal of Haematology Publishes Post-Hoc Analysis of Tavalisse for Adults…
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Home
Biotech
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
ImmunoGen Inc. (NASDAQ:IMGN) Signs Development And Commercialization Partnership For Mirvetuximab With Huadong Medicine For Greater China
Ward Sport
-
October 27, 2020
Jaguar Health Inc. (NASDAQ:JGAX) On Track With Capitalization Strategy As It focuses On Enhancing Mytesi Sales
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Winds Down Probuphine sales In The US And Focuses On ProNeura® Product Development
Akebia Therapeutics Inc. (NASDAQ:AKBA) Presents Positive INNO¬2VATE Phase 3 Clinical Vadadustat Data
Gilead Sciences Inc. (NASDAQ:GILD) Receives FDA Approval For Remdesivir In Treating COVID-19
Fulcrum Therapeutics Inc (NASDAQ:FULC) Kicks Off Its Phase 1 Study Of...
Ward Sport
-
October 26, 2020
0
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Publishes The Findings From Its Investigator Sponsored...
Ward Sport
-
October 26, 2020
0
Bio-Path Holdings (NASDAQ:BPTH) Awarded Notice Of Allowance By USPTO For Prexigerbersen...
Kate Hudson
-
October 26, 2020
0
Moderna Inc. (NASDAQ:MRNA) Completes Enrolment In Phase 3 COVE Study For...
Gavins Felicity
-
October 26, 2020
0
Forte Biosciences Inc (NASDAQ:FBRX) Kicks Off Patient Dosing In Clinical Trial...
Kate Hudson
-
October 26, 2020
0
Amgen, Inc. (NASDAQ:AMGN) And Its Partners Release GALACTIC-HF Phase 3 Trial...
Gavins Felicity
-
October 23, 2020
0
Affimed NV (NASDAQ:AFMD) Administers AFM13 Dose To The First Phase 1...
Matt Wade
-
October 23, 2020
0
Eton Pharmaceuticals Inc (NASDAQ:ETON) Submits Its ET-101 New Drug Application To...
Gavins Felicity
-
October 23, 2020
0
Ovid Therapeutics Inc (NASDAQ:OVID) Discloses Findings From Its ARCADE and ENDYMION...
Kate Hudson
-
October 23, 2020
0
Halozyme Therapeutics, Inc. (NASDAQ:HALO) And Argenx Expand Their Partnership And License...
Kate Hudson
-
October 23, 2020
0
1
2
3
...
56
Page 1 of 56
.td-post-views{ display: none !important; }
